Let’s start with the obvious: no doctor wakes up in the morning and thinks to themselves, “I would like to prescribe a known carcinogen to one of my patients today.” BUT – if your doctor is currently prescribing you Zantac or ranitidine to treat your acid reflux, GERD, or other heartburn related ailments, then that is exactly what is happening. A recent study performed at the request of the Food and Drug Administration (FDA) revealed dangerously high levels of a cancer-causing substance called NDMA present in ranitidine (Zantac). As a result of these findings, the FDA issued a nationwide recall on April 1, 2020, ordering all manufacturers of Zantac, either over the counter or prescription, to remove their products from circulation. The FDA also advised that consumers and patients who currently have these products in their homes should discard them immediately.
It should be fully expected that the dangers inherent in prescribing Zantac are well known to your physician and that they have explored all viable options before continuing to recommend the administration of Zantac. If, for some reason, your physician should prescribe you the medication, it is imperative that you become your own most forceful advocate. As the saying goes, “if I am not for myself, who will be for me?” So, be for yourself, and ask your doctor these basic questions:
If you are unsatisfied with any of your physician’s answers, then seek a second opinion from a medical professional. Remember, medical decision making is a two-way street between the patient and the medical provider, and you have the right to be comfortable with the path your medical providers are setting for you.
In light of the recent findings regarding the cancer causing potential of Zantac and the generic version, ranitidine, Messa & Associates is now filing claims on behalf of patients and consumers who took Zantac for at least one year and subsequently developed cancer. If this sounds like you and you are interested in filing a claim, please contact our offices by calling 215-568-3500 or submitting the qualifying questionnaire at the link below.